Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 8/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.61 |
| ▸ | USP2 | O75604 | 7/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | GAA | P10253 | 5/20 | 0.61 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 3/20 | 0.61 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.61 |
| ▸ | CASP1 | P29466 | 5/20 | 0.53 |
| ▸ | CASP7 | P55210 | 5/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.53 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.53 |
| ▸ | HBB | P68871 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2844010 | 1.00 | SLC16A3 (0.66) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL13486904 | 0.85 | SLC16A3 (0.61) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL13486919 | 0.83 | SLC16A3 (0.61) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL13050804 | 0.83 | SLC16A3 (0.70) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL3206016 | 0.83 | SLC16A3 (0.64) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL3208096 | 0.82 | SLC16A3 (0.59) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL13486876 | 0.82 | SLC16A3 (0.69) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL28109948 | 0.82 | SLC16A3 (0.73) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL12511762 | 0.81 | SLC16A3 (0.83) | SLC16A3MEN1KMT2AUSP2ALDH1A1 | |
| SCHEMBL45609 | 0.80 | SLC16A3 (1.00) | SLC16A3MEN1KMT2AUSP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4624903-A1 | LIQUID SPRAY ANALYSIS | Rolls-Royce plc (GB) | 2025-10-01 | — | — | EP | claimed |
| US-20250297956-A1 | LIQUID SPRAY ANALYSIS | ROLLS-ROYCE PLC (GB) | 2025-09-25 | — | — | US | claimed |
| US-20230201624-A1 | NON-INVASIVE ENERGY UPCONVERSION METHODS AND SYSTEMS FOR IN-SITU PHOTOBIOMODULATION | IMMUNOLIGHT, LLC (US) | 2023-06-29 | — | — | US | claimed |
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4624903-A1 | LIQUID SPRAY ANALYSIS | Rolls-Royce plc (GB) | 2025-10-01 | — | — | EP | disclosed |
| US-20250297956-A1 | LIQUID SPRAY ANALYSIS | ROLLS-ROYCE PLC (GB) | 2025-09-25 | — | — | US | disclosed |
| EP-4567508-A1 | ELECTROPHORETIC CAPSULES ENABLING BLOCKING OF VISIBLE AND NON-VISIBLE WAVELENGTHS | The Boeing Company (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250180958-A1 | ELECTROPHORETIC CAPSULES ENABLING BLOCKING OF VISIBLE AND NON-VISIBLE WAVELENGTHS | THE BOEING COMPANY (US) | 2025-06-05 | — | — | US | disclosed |
| US-20250149336-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-05-08 | — | — | US | disclosed |
| CN-114129544-B | Ultraviolet curable hydrogel resin for transdermal administration, hydrogel, and cataplasm comprising same | Icure药品株式会社 | 2025-03-21 | — | — | CN | disclosed |
| CN-119403840-A | Photocurable composition, method for producing cured film, solid-state imaging element, image display device, and radical polymerization initiator | 富士胶片株式会社 | 2025-02-07 | — | — | CN | disclosed |
| CN-111318238-B | Composite microsphere and preparation method and application thereof | 彩科(苏州)生物科技有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | disclosed |
| WO-2022112459-A1 | LIGHT EMITTING POLYMER MATERIAL PARTICLE | MERCK PATENT GMBH (DE) | 2022-06-02 | — | — | WO | disclosed |
| US-20220153932-A1 | PREPOLYMERS OF 1,1-DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | SIRRUS INC (US) | 2022-05-19 | — | — | US | disclosed |
| US-11324965-B2 | Non-invasive energy upconversion methods and systems | IMMUNOLOIGHT, LLC. (US) | 2022-05-10 | — | — | US | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| US-20220112151-A1 | COMPOSITIONS OF DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | SIRRUS INC (US) | 2022-04-14 | — | — | US | disclosed |
| CN-114129544-A | Ultraviolet-curable hydrogel resin for transdermal administration, hydrogel, and poultice containing same | Icure药品株式会社 | 2022-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220112151-A1 | COMPOSITIONS OF DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | PARG, PARN, LIG1 | SLC16A3 1821/4885MEN1 1628/4885KMT2A 2305/4885 |
| US-20230201624-A1 | NON-INVASIVE ENERGY UPCONVERSION METHODS AND SYSTEMS FOR IN-SITU PHOTOBIOMODULATION | MAVS, NLN, FURIN | SLC16A3 3283/4885MEN1 232/4885KMT2A 4346/4885 |
| US-20220153932-A1 | PREPOLYMERS OF 1,1-DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | PLOD1, COL1A1, PLOD2 | SLC16A3 1816/4885MEN1 1555/4885KMT2A 2902/4885 |
| US-11324965-B2 | Non-invasive energy upconversion methods and systems | FURIN, NFATC1, HAVCR2 | SLC16A3 2056/4885MEN1 274/4885KMT2A 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.